PMCQ Logo
 
Français|Sitemap 
Special FeaturesLast update October 8, 2019

Ask PAAB

Search within Ask Paab
Search by Question ID#

We have enhanced the Ask PAAB section to make it more user-friendly due to the growing number of questions. You can now select a category of interest from the drop down menu above to view existing question and answers or you can also do a search for questions that have been submitted to Ask PAAB since the beginning.

Most Recent Questions and Answers
107
For a launch product is the review time the same as an old product line. When a pharmaceutical submits to PAAB the promotional pieces needed at NoC does PAAB take their 10 full days for review or is it possible to take half of the time because it is a product in launch mode.
  • View Answer [+]
106

If the US indication is the same as the Canadian one, but the US Product Monograph is more comprehensive can it be cited instead?

  • View Answer [+]
105

Je travaille pour une agence de publicité et nous devons préparer un lancement de produit pour un produit pharmaceutique en vente libre, sous restriction, behind the counter (annexe II).

J'aimerais svp avoir les réglèments publicitaires à respecter pour chacune des provinces.

  • View Answer [+]
104

If a disease education piece is being submitted (pre-NOC) that contains no branding and no mention of drug or treatment, would a review paper be an acceptable reference?

  • View Answer [+]
103

If we have a non-branded poster, talking about a disease and with a call to action: talk to your doctor. This poster will be given to the secretary of the doctor's office by the pharmaceutical representative and then will be posted in the examining room. Is this subject to PAAB review?

Also with the poster there will be a booklet disease oriented for patients also to be given to secretary to be left in the examining room. Is this subject to PAAB review?

With that poster there will be a card to be given to the patient by the doctor with the same message and a call to action (talk to your doctor) is this also subject to PAAB review?

  • View Answer [+]
102

Can a pharmaceutical company provide ,upon request from a Third party HCP controlled website, a company produced educational slide deck ( disease and treatment) that has not been reviewed and approved by PAAB.

The third party website wishes to provide these educational slide kits to their members as self learning resources.

  • View Answer [+]
101

Can you please clarify the relationship between the placement of balancing information and a product logo?

It is unclear as to why the product logo must signify the 'end' of the main advertising message.

  • View Answer [+]
100

Are all promotional materials for health care professionals for natural health products required to have PAAB approval? or is this a voluntary action?

  • View Answer [+]
99

Does PAAB have specific rules regarding Pre-NOC communications

Are you allowed to send out a pre-NOC communication that focuses on the disease, patients current unmet need and that a new option for treatment is coming soon?

  • View Answer [+]
98
Do you have an example of how to write an APS? What I am allowed to exclude from the PI?
  • View Answer [+]
Deputy Commissioner  

Jennifer Carroll
Senior Reviewer Communications

To view the PAAB
Code of Advertising Acceptance
click here
Pharmaceutical Advertising
Advisory Board
Upcoming meeting

Have a great summer and see you in September.